Unbiased Analysis of Today's Healthcare Issues
Kapoor et al. (2020) uses rainfall on last weekend before the stay-at-home order as an instrument for social distancing. variables. They find that social distancing works and has persistent effects, especially early on: We test whether earlier social distancing affects the progression of a local COVID-19 outbreak. We exploit county-level rainfall on the last weekend…
Should we infect people with COVID-19? Although most people would say ‘no’, this prospect could help speed the development of a vaccine. In these trials, half the people would be treated with a test vaccine for COVID-19 and half the people would receive a placebo. Then, people in both arms would be infected with COVID-19…
COVID-19 has wreaked havoc for patients, family, the economy and the health care system. In an attempt to provide support to families and businesses, the Coronavirus Aid, Relief, and Economic Security (CARES) Act injects funding into the economy. Further, regulations have been relaxed. As Michael Adelberg and Melissa Garrido write today in the Health Affairs…
Siddhartha Mukherjee has a great article in The New Yorker titled “What the Coronavirus Crisis Reveals About American Medicine“. Much of the article details some of the fundamental problems that causes major failures in the U.S. health care system’s response to COVID-19. Resilience in our medical system will involve more than considerations of physical supplies.…
According to a working paper by Greenstone and Nigam (2020), the answer is a resounding yes! …we project that moderate social distancing would save 1.7 million lives between March 1 and October 1, with 630,000 due to avoided overwhelming of hospital intensive care units. Using the projected age-specific reductions in death and age-varying estimates of…
Looks like remdesivir had some positive results against COVID-19. As reported in STAT news: The preliminary data showed that the time to recovery was 11 days on remdesivir compared to 15 days for placebo, a 31% decrease. The mortality rate for the remdesivir group was 8%, compared to 11.6% for the placebo group; that mortality…
Treating serious cases of COVID-19 is expensive. Treatment may require ICU beds, ventilators and lots of specialized staff time. So clearly, COVID-19 is destroying health insurers bottom lines…isn’t it? Not according to a recent article by Kaiser Health News. Because of the quarantine, many individuals are delaying or foregoing elective surgeries. Of course, the costs…
The Economist has a interesting article on how the Latin American health care system is/will be able to cope with a potential increase in cases of COVID-19. In general, the Latin American health care system may be better than many naive outside observers may think. …Latin American health systems, though still smaller and less well…
On March 9, I wrote a post titled “COVID-19 in context” which showed that COVID-19 (annualized) death rate would make it the the 27th leading cause of death worldwide. By March 21st, it was the 17th leading cause of death. Now, on March 31st, COVID-19 is the 13th leading cause of death (worldwide), if we…
The Coronavirus Aid, Relief, and Economic Security (CARES) Act has been passed by the Senate and signed by the President. There are mixed opinions about this specific bill, but certainly a bailout/relief package of some size was needed. What is in the package? The Committee for a Responsible Federal Budget (CRFB) has a nice visualization.